iBio Inc (IBIO): interesting... back on watch :)

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	567
Posts	15097
Boards Moderated	0
Alias Born	12/01/2013

@LiftedCapital

Re: doebop post# 25382

Thursday, 12/10/2020 9:23:34 PM

Thursday, December 10, 2020 9:23:34 PM

interesting... back on watch :)

http://media.giphy.com/media/tXLpxypfSXvUc/giphy.gif

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent IBIO News

Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/07/2024 04:15:15 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/06/2024 09:02:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 01:03:41 PM
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/25/2024 09:05:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 08:02:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:10:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:08:04 PM
iBio Closes Sale of Manufacturing Facility in Texas • GlobeNewswire Inc. • 06/03/2024 11:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 10:55:47 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:32:43 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:30:55 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:14:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:08:29 PM
iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2024 08:05:00 PM
iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases • GlobeNewswire Inc. • 03/27/2024 11:00:00 AM
iBio Announces $15.0 Million Private Placement • GlobeNewswire Inc. • 03/26/2024 11:35:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:59:30 PM
iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka • GlobeNewswire Inc. • 02/26/2024 12:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:55:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:36:09 PM
iBio Announces Participation in 23rd Annual PepTalk Conference • GlobeNewswire Inc. • 01/16/2024 01:15:00 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/10/2024 06:24:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:30:59 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/04/2024 01:00:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 12:44:38 PM

More IBIO News

InvestorsHub NewsWire

Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM

SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM

Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM

Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM

North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover